Literature DB >> 11556856

Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia.

M S Benninger1, G Gardner, C Grywalski.   

Abstract

BACKGROUND: Spasmodic dysphonia (SD) is a focal dystonia of the larynx. Although individuals with SD have variable degrees of difficulty in everyday communication and speaking, many report significant impairments. The impact of SD on the quality of life of people with the disorder has not been well measured.
OBJECTIVES: To assess the impact of SD using a voice-specific, validated outcomes instrument, the Voice Handicap Index (VHI), and to evaluate the effect of botulinum toxin treatment on quality of life.
METHODS: The VHI measures 3 subscales (physical, functional, and emotional) of impact of a voice disorder as well as a total impact score. The VHI was completed by 30 consecutive patients with SD before receiving botulinum toxin injection and 2 to 4 weeks after injection. Pretreatment scores on the VHI were compared with posttreatment scores.
RESULTS: Pretreatment scores on the VHI showed significant impairment in all 3 subscales (physical, 25.5; functional, 21.4; and emotional, 20.4) and the total score (67.6). Statistically significant improvements occurred in all 3 subscale scores and the total score (P =.001) for the 22 patients who completed the posttreatment survey.
CONCLUSIONS: Spasmodic dysphonia has a significant impact on patients' perception of quality of life as measured by the VHI. Significant improvements in all 3 subscale scores and the total score on the VHI occur after treatment with botulinum toxin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11556856     DOI: 10.1001/archotol.127.9.1083

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  17 in total

Review 1.  ["Off-label use" of botulinum toxin preparations in treatment of spasmodic dysphonia. Position of the German Society of Phoniatrics and Pediatric Audiology].

Authors:  M Ptok; R Schönweiler; T Nawka
Journal:  HNO       Date:  2004-01       Impact factor: 1.284

2.  Application of the Voice Handicap Index in 45 patients with substitution voicing after total laryngectomy.

Authors:  Mieke Moerman; Jean-Pierre Martens; Philippe Dejonckere
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-12-17       Impact factor: 2.503

3.  [Grading of the Voice Handicap Index].

Authors:  E Grässel; U Hoppe; F Rosanowski
Journal:  HNO       Date:  2008-12       Impact factor: 1.284

4.  The consequences of spasmodic dysphonia on communication-related quality of life: a qualitative study of the insider's experiences.

Authors:  Carolyn R Baylor; Kathryn M Yorkston; Tanya L Eadie
Journal:  J Commun Disord       Date:  2005 Sep-Oct       Impact factor: 2.288

Review 5.  Dystonia rating scales: critique and recommendations.

Authors:  Alberto Albanese; Francesca Del Sorbo; Cynthia Comella; H A Jinnah; Jonathan W Mink; Bart Post; Marie Vidailhet; Jens Volkmann; Thomas T Warner; Albert F G Leentjens; Pablo Martinez-Martin; Glenn T Stebbins; Christopher G Goetz; Anette Schrag
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

6.  A qualitative study of interference with communicative participation across communication disorders in adults.

Authors:  Carolyn Baylor; Michael Burns; Tanya Eadie; Deanna Britton; Kathryn Yorkston
Journal:  Am J Speech Lang Pathol       Date:  2011-08-03       Impact factor: 2.408

7.  Outcomes of Onabotulinum Toxin A Treatment for Adductor Spasmodic Dysphonia and Laryngeal Tremor.

Authors:  Priyesh N Patel; Edmond K Kabagambe; Jennifer C Starkweather; Matthew Keller; Vahram Gamsarian; Jane Lee; Vishnutheert Kulkarni; C Gaelyn Garrett; David O Francis
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-04-01       Impact factor: 6.223

8.  Tridimensional assessment of adductor spasmodic dysphonia pre- and post-treatment with Botulinum toxin.

Authors:  P H Dejonckere; K J Neumann; M B J Moerman; J P Martens; A Giordano; C Manfredi
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-31       Impact factor: 2.503

9.  Developing the communicative participation item bank: Rasch analysis results from a spasmodic dysphonia sample.

Authors:  Carolyn R Baylor; Kathryn M Yorkston; Tanya L Eadie; Robert M Miller; Dagmar Amtmann
Journal:  J Speech Lang Hear Res       Date:  2009-08-28       Impact factor: 2.297

10.  Voice in early glottic cancer compared to benign voice pathology.

Authors:  C D L Van Gogh; H F Mahieu; D J Kuik; R N P M Rinkel; J A Langendijk; I M Verdonck-de Leeuw
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-04-25       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.